Galapagos In-Person KOL Event to Discuss New Data Presented at ASH 2023
About The Event
Time: 11:00 AM – 12:30 PM PST
Join Galapagos for an in-person KOL event during the 65th ASH Annual Meeting & Exposition in San Diego. The event will feature Key Opinion Leaders who will review the results observed in the ongoing Phase 1/2 CD19 CAR-T studies with GLPG5201 and GLPG5101.
The event will include a discussion of the potential for CAR-T candidates, manufactured using the Galapagos Point-of-Care platform, to improve survival for patients with a broad range of B-cell malignancies. Galapagos leadership, including Paul Stoffels, MD, CEO and Chairman, will provide updates on:
- GLPG5201 (CD19 CAR-T) potential in relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or without Richter’s transformation (RT)
- GLPG5101 (CD19 CAR-T) potential in relapsed/refractory non-Hodgkin lymphoma (rrNHL)
A live question and answer will follow the formal presentations.
*Please note this registration is for in-person attendance only. If you would like to register for the webcast, please click here: https://edge.media-server.com/mmc/p/wvt8b3kk/